Sapient Capital’s Merck MRK Stock Holding History

Sapient Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.06M	Sell	7,267 -60	-0.8%	-$8.29K	0.01%	192
2026 Q2	$948K	Sell	7,327 -9,075	-55%	-$1.06M	0.01%	206
2026 Q1	$1.99M	Buy	16,402 +6,365	+63%	+$735K	0.03%	156
2025 Q4	$1.07M	Buy	+10,037	New	+$942K	0.02%	197
2025 Q3	–	Sell	-11,782	Closed	-$942K	–	395
2025 Q2	$942K	Sell	11,782 -318,010	-96%	-$25.3M	0.02%	191
2025 Q1	$29.9M	Sell	329,792 -66	-0%	-$6.16K	0.59%	38
2024 Q4	$33.1M	Sell	329,858 -139,644	-30%	-$14.4M	0.63%	36
2024 Q3	$53.7M	Sell	469,502 -5,174	-1%	-$615K	1.08%	17
2024 Q2	$59.1M	Sell	474,676 -1,545	-0.3%	-$199K	1.23%	17
2024 Q1	$63.2M	Sell	476,221 -7,642	-2%	-$942K	1.4%	14
2023 Q4	$53.1M	Buy	+483,863	New	+$50.2M	1.37%	13

Other funds holding MRK

Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.95B AUM 39.67% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Sapient Capital's MRK Position: Q3 2026 in Review

Sapient Capital reduced its Merck (MRK) stake by 0.82% in Q3 2026, selling an estimated $8.29K and leaving 7,267 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #192.

Sapient Capital first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $63.2M in Q1 2024. 1,277 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

Sapient Capital held 7,267 shares of Merck worth $1.06M as of Q3 2026.
Sapient Capital sold 60 Merck shares in Q3 2026, an estimated $8.29K.
Merck made up 0.01% of Sapient Capital's portfolio in Q3 2026, its #192 holding.
Sapient Capital first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
Sapient Capital's Merck position peaked at $63.2M in Q1 2024.
1,277 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.